Table 3. MiR-125a and MMP11 expression correlated with clinical features of patients.
MiR-125a | P value | MMP11 | P value | ||||
Parameter | Group | Low | High | – | + | ||
Age | <56 | 20 | 20 | 1.00 | 18 | 22 | 0.36 |
>56 | 20 | 20 | 14 | 26 | |||
Gender | Male | 28 | 28 | 0.64 | 18 | 36 | 0.08 |
Female | 12 | 14 | 14 | 12 | |||
HBV | − | 5 | 9 | 0.24 | 9 | 5 | 0.05 |
+ | 35 | 31 | 23 | 43 | |||
Metastasis | Without | 17 | 32 | 0.001 | 26 | 23 | 0.003 |
With | 23 | 8 | 6 | 25 | |||
AFP | Low | 19 | 21 | 0.37 | 18 | 22 | 0.36 |
High | 21 | 19 | 14 | 26 | |||
T stage | I+II | 10 | 27 | <0.001 | 19 | 18 | 0.06 |
III+IV | 30 | 13 | 13 | 30 |
The associations of miR-125a and MMP11 with clinical features were detected by Kruskal-Wallis H or Mann–Whitney U test. *P < 0.05 was considered statistically significant.